Salicylanilide Modulation of Endosomal pH to Prevent C. difficile Recurrence

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current treatments for Clostridium difficile infections are limited by recurrence rates and the disruption of gut microbiota, with existing antibiotics often failing to prevent recurrence and causing dysbiosis.

Innovation Solution

Administration of salicylanilides, such as niclosamide ethanolamine (NEN), which targets the host cells' endosomal pH to inhibit toxin entry and reduce virulence without affecting the gut microbiota, thereby reducing infection recurrence and maintaining microbiota diversity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional antibiotics are used to treat C. difficile infection, then the infection is cured, but the gut microbiota is disrupted causing dysbiosis and recurrence

Engineering Contradiction:

Improveinfection cure rateVSAvoidgut microbiota disruption

Core Design Contradiction:

ReliabilityVSObject-generated harmful factors

Solution Approach 1:

Instead of targeting and killing the pathogen directly (conventional antibiotic approach), the invention targets the host cell's endosomal pH to prevent toxin entry. This inverted strategy blocks the pathogen's virulence mechanism without eliminating the microbiota, thereby curing the infection while avoiding dysbiosis and recurrence

Inventive Principle:

Principle #13The other way round (Inversion)

Solution Approach 2:

The invention uses salicylanilides as an intermediary agent that modifies the host cell's endosomal environment (pH modulation) to prevent toxin internalization. This intermediary approach blocks the harmful toxin-pathogen interaction without directly confronting the pathogen, thus preserving the gut microbiota while treating the infection

Inventive Principle:

Principle #24Intermediary (Mediator)

2Quantity of substance

If antibiotics are administered to eliminate C. difficile, then bacterial load is reduced, but recurrence rates increase due to microbiota damage

Engineering Contradiction:

Improvepathogen loadVSAvoidinfection recurrence

Core Design Contradiction:

Quantity of substanceVSDuration of action of stationary object

Solution Approach 1:

Rather than reducing pathogen load through antibiotic killing (which damages microbiota and enables recurrence), the invention inverts the approach by blocking toxin entry into host cells. This prevents the pathogen from establishing harmful effects without eliminating the microbiota, thereby reducing both pathogen impact and recurrence risk

Inventive Principle:

Principle #13The other way round (Inversion)

Solution Approach 2:

The invention converts the host cell's endosomal acidification mechanism (which normally facilitates toxin entry) into a protective feature by using salicylanilides to modulate pH and prevent toxin internalization. This transforms a potential harmful pathway into a benefit, reducing both pathogen effectiveness and recurrence

Inventive Principle:

Principle #22Blessing in disguise (Convert harm into benefit)

3Object-generated harmful factors

If salicylanilides are used to inhibit toxin entry, then virulence is reduced and microbiota is preserved, but the mechanism targets host cells rather than pathogen

Engineering Contradiction:

Improvetoxin entry inhibitionVSAvoidtargeting mechanism

Core Design Contradiction:

Object-generated harmful factorsVSDevice complexity

Solution Approach 1:

The invention deliberately inverts the conventional targeting approach by acting on host cells rather than the pathogen. By modulating host endosomal pH, salicylanilides prevent toxin entry without needing to directly target or kill the pathogen, simplifying the mechanism while achieving superior clinical outcomes including reduced recurrence

Inventive Principle:

Principle #13The other way round (Inversion)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

NEN effectively reduces primary and recurrent C. difficile infections by inhibiting toxin entry into host cells, protecting against weight loss, diarrhea, and mortality, while preserving the gut microbiota's diversity and composition.

Implementation Method 1

the salicylanilide increases the pH of host cell endosomal compartments

Methodology Applied

Scientific EffectpH increase:

Data Source

PatentUS11166926B2Compositions and methods for protecting a host from enteric toxigenic pathogens

Publication Date: 2021.11.09 HOSPITAL FOR SICK CHILDREN

AI summary

A method of protecting a host from an enteric toxigenic pathogen comprises administering a salicylanilide to the host. A method of reducing virulence of an enteric toxigenic pathogen comprises administering a salicylanilide to a host infected with or at risk of infection with pathogen. A method of reducing recurrence of an infection caused by an enteric toxigenic pathogen, comprises administering a salicylanilide to a host previously infected with the pathogen.